94 related articles for article (PubMed ID: 33206859)
1. INSULIN AND INSULIN RECEPTOR GENE POLYMORPHISMS AND SUSCEPTIBILITY TO NONALCOHOLIC FATTY LIVER DISEASE.
Nobakht H; Mahmoudi T; Sabzikarian M; Tabaeian SP; Rezamand G; Asadi A; Farahani H; Dabiri R; Mansour-Ghanaei F; Maleki I; Zali MR
Arq Gastroenterol; 2020; 57(2):203-208. PubMed ID: 33206859
[TBL] [Abstract][Full Text] [Related]
2. An exon variant in insulin receptor gene is associated with susceptibility to colorectal cancer in women.
Mahmoudi T; Majidzadeh-A K; Karimi K; Karimi N; Farahani H; Dabiri R; Nobakht H; Dolatmoradi H; Arkani M; Zali MR
Tumour Biol; 2015 May; 36(5):3709-15. PubMed ID: 25557790
[TBL] [Abstract][Full Text] [Related]
3. Association of metabolism-related genes polymorphisms with adenocarcinoma of the oesophagogastric junction: Evidence from 2261 subjects.
Tang W; Liu J; Zhong Z; Qiu H; Kang M
J Cell Biochem; 2019 Nov; 120(11):18689-18701. PubMed ID: 31211453
[TBL] [Abstract][Full Text] [Related]
4. A 3'-untranslated region variant (rs2289046) of insulin receptor substrate 2 gene is associated with susceptibility to nonalcoholic fatty liver disease.
Dabiri R; Mahmoudi T; Sabzikarian M; Asadi A; Farahani H; Nobakht H; Maleki I; Mansour-Ghanaei F; Derakshshan F; Zali MR
Acta Gastroenterol Belg; 2020; 83(2):271-276. PubMed ID: 32603046
[TBL] [Abstract][Full Text] [Related]
5. Association of rs5742612 Polymorphism in the Promoter Region of IGF1 Gene with Nonalcoholic Fatty Liver Disease: A Case-Control Study.
Nobakht H; Mahmoudi T; Rezamand G; Tabaeian SP; Jeddi G; Asadi A; Farahani H; Dabiri R; Mansour-Ghanaei F; Kaboli SA; Derakhshan F; Zali MR
Lab Med; 2022 Sep; 53(5):504-508. PubMed ID: 35713614
[TBL] [Abstract][Full Text] [Related]
6. The Leu72Met (rs696217 G>T) Polymorphism of the Ghrelin Gene Might Be a Protective Factor for Nonalcoholic Fatty Liver Disease.
Tabaeian SP; Mahmoudi T; Sabzikarian M; Rezamand G; Dabiri R; Nobakht H; Asadi A; Farahani H; Mansour-Ghanaei F; Zali MR
J Gastrointestin Liver Dis; 2021 Jun; 30(2):233-239. PubMed ID: 34174062
[TBL] [Abstract][Full Text] [Related]
7. The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study.
Uygun A; Ozturk K; Demirci H; Oztuna A; Eren F; Kozan S; Yilmaz Y; Kurt O; Turker T; Vatansever S; Alper E; Unsal B
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):441-447. PubMed ID: 28253210
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.
Skrgatić L; Baldani DP; Gersak K; Cerne JZ; Ferk P; Corić M
Coll Antropol; 2013 Mar; 37(1):141-6. PubMed ID: 23697264
[TBL] [Abstract][Full Text] [Related]
9. The "GG" genotype of rs26802 variant in the ghrelin gene is a potential protective factor against nonalcoholic fatty liver disease.
Rezamand G; Mahmoudi T; Tabaeian SP; Farahani H; Shahinmehr F; Nobakht H; Dabiri R; Asadi A; Mansour-Ghanaei F; Zali MR
Physiol Int; 2021 Sep; 108(3):342-352. PubMed ID: 34529585
[TBL] [Abstract][Full Text] [Related]
10. RESISTIN GENE POLYMORPHISM AND NONALCOHOLIC FATTY LIVER DISEASE RISK.
Tabaeian SP; Mahmoudi T; Rezamand G; Nobakht H; Dabiri R; Farahani H; Asadi A; Zali MR
Arq Gastroenterol; 2022; 59(4):483-487. PubMed ID: 36515343
[TBL] [Abstract][Full Text] [Related]
11. A visfatin gene promoter polymorphism (rs1319501) is associated with susceptibility to nonalcoholic fatty liver disease.
Mahmoudi T; Ghorbani D; Rezamand G; Dehestan N; Jeddi G; Asadi A; Nobakht H; Dabiri R; Farahani H; Tabaeian SP; Zali MR
Per Med; 2023 Mar; 20(2):157-165. PubMed ID: 37199515
[No Abstract] [Full Text] [Related]
12. Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes.
Hsieh CJ; Wang PW; Hu TH
PLoS One; 2015; 10(6):e0127521. PubMed ID: 26042596
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding protein 3 promoter variant (rs2854744) is associated with nonalcoholic fatty liver disease.
Mahmoudi T; Nouri S; Zarei F; Najafabadi ZN; Sanei M; Sayedsalehi S; Rezamand G; Asadi A; Dabiri R; Nobakht H; Farahani H; Tabaeian SP; Zali MR
Arch Endocrinol Metab; 2023 Nov; 68():e230017. PubMed ID: 37948568
[TBL] [Abstract][Full Text] [Related]
14. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
Wang CW; Lin HY; Shin SJ; Yu ML; Lin ZY; Dai CY; Huang JF; Chen SC; Li SS; Chuang WL
Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282
[TBL] [Abstract][Full Text] [Related]
15. Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance.
Petersen MC; Madiraju AK; Gassaway BM; Marcel M; Nasiri AR; Butrico G; Marcucci MJ; Zhang D; Abulizi A; Zhang XM; Philbrick W; Hubbard SR; Jurczak MJ; Samuel VT; Rinehart J; Shulman GI
J Clin Invest; 2016 Nov; 126(11):4361-4371. PubMed ID: 27760050
[TBL] [Abstract][Full Text] [Related]
16. Association of genetic variants in INS (rs689), INSR (rs1799816) and PP1G.G (rs1799999) with type 2 diabetes (T2D): a case-control study in three ethnic groups from North-West India.
Sokhi J; Sikka R; Raina P; Kaur R; Matharoo K; Arora P; Bhanwer A
Mol Genet Genomics; 2016 Feb; 291(1):205-16. PubMed ID: 26251103
[TBL] [Abstract][Full Text] [Related]
17. [Interaction of polymorphisms of monocyte chemoattractant protein-1 receptor CCR2 gene 190A/G, nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene C242T and cigarette smoking increases the risk of nonalcoholic fatty liver disease].
Zhang C; Guo L
Wei Sheng Yan Jiu; 2015 Sep; 44(5):730-7. PubMed ID: 26591766
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism in
Kapil S; Duseja A; Sharma BK; Singla B; Chakraborti A; Das A; Ray P; Dhiman RK; Chawla Y
World J Gastroenterol; 2016 Nov; 22(42):9346-9355. PubMed ID: 27895422
[TBL] [Abstract][Full Text] [Related]
19. Insulin receptor substrate 2 gene Gly1057Asp polymorphism is a risk factor for nonalcoholic fatty liver disease.
Nouri S; Mahmoudi T; Hojjati F; Najafabadi ZN; Shafiee R; Sayedsalehi S; Dehghanitafti A; Ardalani A; Kohansal K; Rezamand G; Asadi A; Nobakht H; Dabiri R; Farahani H; Tabaeian SP; Zali MR
Lab Med; 2024 Mar; 55(2):215-219. PubMed ID: 37481466
[TBL] [Abstract][Full Text] [Related]
20. Association between the CYBA and NOX4 genes of NADPH oxidase and its relationship with metabolic syndrome in non-alcoholic fatty liver disease in Brazilian population.
Rabelo F; Stefano JT; Cavaleiro AM; Lima RVC; de Campos Mazo DF; Carrilho FJ; Correa-Giannella ML; Oliveira CP
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):330-335. PubMed ID: 30087027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]